Ask Warren

HEM Pharma

376270 · KOSDAQ · ₩376270 · HEM파마

₩26,200▲ ₩50 (0.19%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩4.6B₩4.9B₩3.7B₩3B₩2.8B₩3.5B₩6.3B₩3.2B
Cost of sales₩2.4B₩4.8B₩4.2B₩2.7B₩2.4B₩3B₩5.5B₩3B
Gross profit₩2.2B₩146M−₩500M₩234M₩398M₩500M₩777M₩187M
Operating income−₩2.9B−₩3.8B−₩6.8B−₩3.6B−₩2.9B−₩2.4B−₩2B−₩2.2B
Net income₩1.4B−₩4B−₩15B−₩3.5B−₩3.3B−₩2.3B−₩2B−₩2.2B
Net income to shareholders₩1.5B−₩4.2B−₩15B−₩3.5B−₩3.3B−₩2.3B−₩2B−₩2.2B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩57B₩53B₩52B₩36B₩36B₩37B₩37B₩23B
Current assets₩23B₩22B₩23B₩9.6B₩14B₩18B₩17B₩6.7B
Cash and equivalents₩7.6B₩12B₩14B₩5.3B₩10B₩7.4B₩6.3B₩3.1B
Total liabilities₩41B₩51B₩47B₩17B₩14B₩12B₩11B₩10B
Current liabilities₩35B₩45B₩40B₩12B₩9.7B₩9B₩9.1B₩8.5B
Borrowings₩11B₩17B₩17B₩11B₩9.6B₩8.1B₩6.5B₩6.5B
Total equity₩16B₩1.7B₩5.2B₩19B₩22B₩24B₩26B₩12B
Shareholders' equity₩14B₩1.4B₩5B₩18B₩22B₩24B₩26B₩12B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩885M₩847M−₩5B−₩2.4B−₩195M−₩765M−₩3.4B−₩1.8B
Capital spending₩5.9B−₩1.5B−₩17B₩4.1B₩2.7B₩188M₩3.9B₩404M
Free cash flow−₩6.8B−₩640M−₩22B−₩6.5B−₩2.9B−₩953M−₩7.3B−₩2.2B

Consolidated where available. Amounts in won.

Also known as: HEM Pharma / HEM파마 / 376270 / KRX:376270

Source: KRX statistical information